help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armstrong, D. G.
Right arrow Articles by Webb, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armstrong, D. G.
Right arrow Articles by Webb, R.
Endocrinology Vol. 139, No. 4 2146-2154
Copyright © 1998 by The Endocrine Society


ARTICLES

Insulin-Like Growth Factor Binding Protein -2 and -4 Messenger Ribonucleic Acid Expression in Bovine Ovarian Follicles: Effect of Gonadotropins and Developmental Status1

D. G. Armstrong, G. Baxter, C. G. Gutierrez, C. O. Hogg, A. L. Glazyrin2, B. K. Campbell, T. A. Bramley and R. Webb

Division of Development and Reproduction (D.G.A., G.B., C.G.G., C.O.H., A.L.G.), Roslin Institute, (Edinburgh), Roslin, Midlothian, EH25 9PS, Scotland, United Kingdom; University of Edinburgh (B.K.C., T.A.B.), Department of Obstetrics and Gynaecology, Centre of Reproductive Biology, Edinburgh, EH3 9EW, Scotland, United Kingdom; and University of Nottingham (R.W.), Division of Agriculture and Horticulture, School of Biological Sciences, Sutton-Bonington Campus, Loughborough, Leicstershire, LE12 5RD, United Kingdom

Address all correspondence and requests for reprints to: D. G. Armstrong, Division of Development and Reproduction, Roslin Institute (Edinburgh), Roslin, Midlothian, EH25 9PS, Scotland, United Kingdom. E-mail: david.armstrong{at}bbsrc.ac.uk


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
This work is concerned with the role of insulin-like growth factor binding protein (IGFBP)-2 and -4 in the regulation of IGF bioactivity in bovine follicles during the development of dominance. We measured the expression of IGFBP-2 and -4 messenger RNA (mRNA) in small (1–4 mm) gonadotropin-sensitive follicles and medium (4–8 mm) and large (>8 mm) gonadotropin-dependent follicles using in situ hybridization. In healthy nonatretic bovine follicles, IGFBP-2 and -4 mRNA expression was confined to granulosa and theca tissue, respectively. Moreover, during the development of follicular atresia, there were distinct changes in the temporal and spatial expression of these genes. IGFBP-2 immunoactivity was localized in granulosa tissue and the basement membrane of healthy preantral follicles, whereas IGFBP-4 immunoactivity was localized in both theca and granulosa tissue. Of particular interest was the lack of IGFBP-2 mRNA expression in large (>8 mm) gonadotropin-dependent follicles, an observation that was confirmed by the lack of immunoreactive IGFBP-2 in these follicles. The regulation of IGFBP-2 and -4 mRNA expression in granulosa and theca cells was analyzed using a serum-free cell culture system. FSH inhibited the expression of IGFBP-2 mRNA in granulosa cells, whereas LH stimulated IGFBP-4 mRNA expression in theca cells. Our results provide evidence for the existence of different roles for IGFBP-2 and -4 in the developing follicle.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE PRIMARY regulators of ovarian follicular growth and development are the gonadotropins. It has become increasingly apparent, however, that additional locally produced factors are involved in modulating the response of the developing follicle to FSH and LH. The ultimate fate of a follicle is dependent, therefore, on the interaction of a complex array of extra- and intraovarian signals. The insulin-like growth factor (IGF) system plays a central role in these interactions, regulating both the proliferative and steroidogenic responses of thecal and granulosa cells to gonadotropins (1, 2, 3).

Most of the early concepts on the intraovarian control of ovarian function (particularly those related to the IGF system) were developed using in vitro rodent models (4). However, there is considerable species variation in both the temporal and spatial patterns of growth factor expression during folliculogenesis, and it would be wrong to extrapolate observations made in rats and mice to other species, many of which show considerable differences in their patterns of follicle growth. For example, in rodents (5) and pigs (6), the expression of messenger RNA (mRNA) encoding IGF-I is confined to granulosa tissue, whereas in humans, mRNA encoding IGF-II, but not IGF-I, is localized to granulosa tissue (7). We have detected the expression of mRNA encoding IGF-II in thecal tissue of bovine ovarian follicles (2), and a similar spatial distribution has been described in sheep (8). The expression of mRNA encoding IGF-I in ruminants remains controversial. Leeuwenberg et al. (9) detected IGF-I mRNA in ovine granulosa and theca tissue, whereas Perks et al., (8) failed to detect the expression of mRNA encoding IGF-I in ovarian follicles from the ewe. We have recently demonstrated that nonluteinized bovine granulosa cells do not produce IGF-I in serum-free cultures (10).

The bioactivity of IGFs is controlled by their association with a family of, at least six, specific IGF binding proteins (IGFBPs), which have been characterized, after purification and/or complementary DNA (cDNA) isolation and sequencing (11, 12). As with IGFs, the spatial expression of these binding proteins within ovarian follicles is species-specific. In the sheep, for example, IGFBP-4 is produced by theca cells (13, 14), whereas in the pig, this binding protein is expressed in granulosa cells (15). In contrast, IGFBP-4 is expressed in both granulosa and thecal tissue in women (16).

In all ovarian cell culture systems examined, so far, IGFBPs attenuate the actions of IGFs (17, 18, 19). A decrease in follicular IGFBP production, therefore, would be expected to result in increased biological activity of locally produced IGF and thus increase the response of the follicle to gonadotropins. Although the observed changes in the concentration of IGFBPs in follicular fluid during folliculogenesis agree with this hypothesis (14, 17), the precise role of individual binding proteins within the developing follicle remains obscure.

We are currently analyzing the IGF-system in the bovine ovary, and we are particularly interested in how IGFBPs regulate the development and maintenance of follicular dominance. The cow is a monoovulatory species and provides a particularly useful model to study dominance (20, 21, 22). Greater than 96% of cows produce a single ovulation per estrous cycle, and mechanisms regulating dominance in this species, therefore, are presumed to be more prominent than in polyovulating species. Follicle growth in cattle occurs in a wave-like pattern, with two or three waves per estrous cycle. Each wave is associated with the selection of a large ovulatory, gonadotropin-dependent follicle from a cohort of growing, gonadotropin-sensitive follicles. This so-called dominant follicle suppresses the growth of the remaining follicles within the cohort (subordinate follicles) and will eventually ovulate if its selection coincides with the luteolytic phase of the cycle.

We have developed a serum-free primary cell culture system for ruminant granulosa and theca cells in which the follicular phenotype is maintained for up to 6 days in culture (23, 24). Our previous work, using ovine cultures, indicated that IGFBP-2 and -4 are the major binding proteins produced by ruminant granulosa and thecal cells (14). In an attempt to define the mechanisms by which IGFBPs modulate the bioactivity of IGFs in the intact bovine ovarian follicle more precisely, we have examined the effects of gonadotropin on IGFBP-2 and -4 mRNA expression in vitro and have compared this with the spatial/temporal changes in IGFBP-2 and -4 mRNA expression during the development of small (1–4 mm) gonadotropin-sensitive follicles into medium-sized (4–8 mm) and large (>8 mm) gonadotropin-dependent follicles, using in situ hybridization. From the results of this investigation, we have developed a hypothesis for the role of IGFBP-2 and-4 in the development of follicular dominance in the cow.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Materials
Cell culture material was obtained from Gibco BRL Life Technologies Ltd. (Paisley, UK). Recombinant human Long R3 IGF-I (LR3-IGF-I, media grade) and recombinant human IGF-I was purchased from Gropep Pty Ltd (Adelaide, South Australia, Australia). FSH (USDA-bFSH-I-2; potency 854IU/mg) was donated by the U.S. Department of Agriculture and LH (NIDDK-oLH-S26; potency 2.3IU/mg) was donated by the National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases (Torrance, CA)

Collection of tissue and characterization of follicles
Ovaries were obtained from the local abattoir. They were either processed directly for cell cultures or were divided into blocks, had follicle diameters measured, were frozen in liquid nitrogen, and stored at -70 C until required for subsequent in situ hybridization or immunohistochemistry. Follicles were classified morphologically as healthy, atretic, or grossly atretic. Healthy follicles had an intact basement membrane and a healthy granulosa cell layer. Atretic follicles had fewer granulosa cells with local disruption in the basement membrane. Cells with pycnotic nuclei were identified within the granulosa layer. Follicles with a more extensively disrupted basement membrane, with a significant reduction in the number of granulosa cells and an increase in the number of pycnotic nuclei, were classified as grossly atretic (25).

Granulosa and theca primary cell cultures
Granulosa and theca cells from medium-sized (4–8 mm) gonadotropin-dependent follicles were isolated and pooled. Three million cells were cultured in duplicate in 10 ml of the appropriate culture medium for up to 96 h, as described previously (24). Granulosa cell cultures were supplemented with 10 ng/ml of insulin and with 0, 1, or 50 ng/ml FSH or 0 or 100 ng/ml LH. Under those conditions FSH, at a dose of 1 ng/ml, maintained estradiol production for up to 5 days in culture. The 50 ng/ml dose of FSH inhibited estradiol production and increased progesterone production. LH had no effect on the production of either estradiol or progesterone by granulosa cells under the conditions described here.

After isolation of the granulosa cells, the remainder of the follicle wall was dispersed by enzymatic digestion to isolate the theca cells (26). Briefly, theca shells were digested at 37 C in an enzymatic mixture (Sigma Chemical Co. Ltd., Poole, UK) containing collagenase (type 1A) (5 mg/ml), pronase E (1 mg/ml), and hyaluronidase (1 mg/ml) in 20 ml of Dulbecco’s PBS without calcium chloride and magnesium chloride. After 20 min, 200 µl DNA (2 mg/ml) was added, and the incubation continued. The reaction was stopped by addition of fetal donor serum (1 ml) and the solution containing the cells was transferred to centrifuge tubes, where it was diluted with an equal volume of theca cell culture medium consisting of DMEM:Hams F12 (1:1) media supplemented with bicarbonate, 15 mM HEPES, 100 IU/ml penicillin, 0.1 mg/ml streptomycin, 3 mM L-glutamine, 0.1% BSA, 20 ng/ml estradiol, 2.5 µg/ml transferrin, and 4 ng/ml selenium; and the solution was centrifuged. After a second wash, the cells were resuspended in 15 ml of theca culture medium, and the cell number and viability were estimated in a hemocytometer using Trypan blue exclusion. Aliquots containing 3 x 106 viable theca cells were then cultured in the theca culture medium, supplemented with insulin (100 ng ml) and 0 or 100 ng/ml LH, in a humidified atmosphere with 3.8% CO2 at 37 C replacing media every 48 h. Under those conditions, LH significantly increased the production of both androstenedione and progesterone.

RT-PCR
RNA was isolated from granulosa and theca cells after 96 h of culture using RNeasy spin columns (Qiagen Ltd., Crawley, UK), according to the manufacturer’s instructions. Concentrations were estimated by absorbance at 260 nm, and the samples were stored in RNase-free 10 mM Tris buffer, pH 74, containing 1 mM EDTA at -80 C until required. The A260/A280 ratio for all RNA samples was more than 1.8. First-strand cDNA synthesis was carried out using SUPERSCRIPT II RT (Life Technologies), using a modification of the method described previously (27). Briefly, total RNA (1 µg) was reverse transcribed in 20 µl Tris buffer (50 mmol/liter; pH 8.3) supplemented with KCl (75 mmol/liter), MgCl2 (3 mmol/liter), dithiothreitol (10 mmol/liter), deoxynucleotide triphosphates (0.5 µmol/liter), acetylated BSA (0.1 mg/ml), random hexamers (50 µmol/liter), recombinant RNasin ribonuclease inhibitor (Promega, Southampton, UK) (4 U), and SUPERSCRIPT II RT (13.5U) at 37 C for 60 min. The PCR reaction was carried out using 2 µl of the RT reaction (equivalent to 0.1 µg of the original total RNA) in 8 µl PCR buffer. The primers used for the PCRs are shown in Table 1Go. Samples were heated to 94 C for 3 min and amplified for 25 cycles (94 C for 1 min; 55 C for 1 min, and 72 C for 1 min). The final 72 C incubation was continued for a further 4 min. RT blanks, RNA blanks, and PCR blanks (no cDNA products) and positive controls were included in each analysis. Products were visualized by electrophoresis on 4% agarose gels (NuSieve GTG Agarose; FMC Bioproducts, Rockland, ME). In all experiments, RT blanks, RNA blanks, and PCR blanks were negative. Identities of the PCR products were confirmed by restriction endonuclease digestion and by DNA sequencing of representative samples.


View this table:
[in this window]
[in a new window]
 
Table 1. Primer pairs used for PCR amplification of IGFBP-2 and -4 cDNAs

 
Quantitation of the PCR products was performed using an NIH image analyzer. Adenosine triphosphatase (ATPase) primers were used as internal controls and to control for loading variations between samples. Under the conditions described here, the amount of the amplified IGFBP-2 and -4 cDNA product was proportional to the number of thermocycles in the PCR reaction.

IGFBP-2 and -4 RNA probes
A plasmid containing the bovine IGFBP-2 probe was a gift from Dr. M. Lucy (University of Missouri). The probe corresponded to positions 1084–1192 of a bovine IGFBP-2 cDNA (28). The IGFBP-4 probe was prepared by RT-PCR (see previous section) using the oligos described in Table 1Go. The 227-bp amplified fragment was cloned into pGEM-T (Promega Ltd., Southampton, UK) using standard procedures, and it was sequenced to confirm its identity and orientation within the plasmid. The construct was linearized with NcoI and was used as a template to generate 35S-labeled antisense RNA, using SP6 DNA-dependent RNA polymerase. A sense RNA probe was prepared, using T7 DNA-dependent RNA polymerase, after linearization with SalI.

In situ hybridization
Frozen sections (14 µm) were dehydrated, fixed, and probed with 35S-labeled IGFBP-2 and -4 riboprobes, according to the method described by Xu et al. (29). After the final high stringency wash, the sections were dipped in autoradiographic K2 photographic emmulsion (Ilford Limited, Mobberley, UK) and exposed for 3 weeks at 4 C. Sections were then developed (Kodak D-19) (IBI Limited, Cambridge, UK) and fixed (Ilford Hypam fixer) before staining in hematoxylin and eosin. The sections were finally mounted in DPX mountant, before microscopic examination, using both light- and dark-field illumination. Each follicle was examined in six serial sections. The antisense RNA probes for IGFBP-2 and -4 were each hybridized to two of the sections, and the remaining two slides were hybridized with the sense RNA probe for each binding protein.

Image analysis
The intensity of the in situ hybridization signal was analyzed using an NIH-Image analysis system (NIH, Bethesda, MD). The number of graphic pixels occupied by silver grains (identified by a set gray threshold) within a defined area of the tissue section was counted and presented as a percentage of the total pixel number within the defined area. The hybridization intensity, therefore, is presented as the percentage of occupied pixels to total pixels within a defined area of the tissue. Background hybridization intensity, measured with the sense RNA probes, was subtracted from the measurements obtained with the antisense probes to give the final hybridization signal. Within each follicle, three separate fields were analyzed for each probe. There was no significant difference (P > 0.05) in hybridization intensity obtained with antisense and sense RNA probes within a nonexpressing region of a tissue section. Under the conditions described here, the hybridization signal was proportional to the length of time the slides were exposed to photographic emmulsion (for up to 3 weeks).

Immunohistochemistry
Frozen sections (10 µm) were immersed in blocking buffer (50 mmol/liter Tris buffer, pH 7.2, supplemented with 5% BSA (RIA grade) and 1% Tween 20) for 2 h at room temperature. The solution was removed, and the sections were immersed in blocking buffer containing the primary antibody (rabbit antibovine IGFBP-2 or rabbit antihuman IGFBP-4; Upstate Biotechnology Incorporated, Lake Placid, NY) diluted 1:1000 and 1:500 in blocking buffer for IGFBP-2 and -4 antibodies, respectively, overnight at 4 C. The sections were washed and stained using an antirabbit IgG biotin-avidin, peroxidase kit (Sigma), according to the manufacturer’s instructions.

The IGFBP-2 antisera cross-reacted with a single protein band (Mr = 34 x 103) in immunoblots of bovine follicular fluid obtained from dominant follicles. In contrast, the IGFBP-4 antiserum was less specific, and it recognized three proteins, two of which (Mr = 25 and 29 x 103) were assumed to be the nonglycosylated and glycosylated forms of IGFBP-4. The third protein (Mr = 34 x 103) was identical in size to that detected by the IGFBP-2 antibody (results not shown).

Steroid measurement
Androstenedione and progesterone were measured by RIA (30). Estradiol-17ß was also measured by RIA, according to the method described by Webb et al (31).

Statistical analysis
Steroid production by cell cultures and band intensities of PCR products are presented as mean ± SEM (three cultures with two replicates). Comparison between treatments was assessed by repeated-sample ANOVA. The effects of FSH or LH (fixed effects) were analyzed using the mixed models, allowing for variation caused by culture and different pools of cells (random effects).

The effect of follicle size and health status on the intensity of the in situ hybridization signal was determined by ANOVA and the {chi}2 test.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IGFBP mRNA expression in primary cultures of granulosa and theca cells
IGFBP-2 and -4 mRNA expression was measured in granulosa and theca cells, respectively, using a semi quantitative RT-PCR assay. The sequences of the amplified products, obtained using the primers described in Table 1Go, were identical to the expected bovine IGFBP-2 and -4 sequences (results not shown). Expression was measured in cells cultured for 4 days in the presence and absence of either FSH (granulosa) or LH (theca). Typical agarose gels are shown in the insets to Fig. 1Go. The results from three separate experiments, obtained after image analysis of the PCR gels, are presented. Granulosa IGFBP-2 mRNA expression (Fig. 1aGo) was significantly reduced (P < 0.001) after treatment with FSH (50 ng/ml) for 4 days. IGFBP-4 mRNA expression (Fig. 1bGo) was increased significantly (P < 0.05) in thecal cells cultured in the presence of LH (100 ng/ml). There was no change in the amount of the amplified cDNA of the bands obtained with primers for ATPase between all the incubations.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 1. RT-PCR analysis of IGFBP-2 (a) and IGFBP-4 (b) mRNA expression in cultures of granulosa and theca cells, respectively. Cells were collected from medium-sized (4–8 mm in diameter) gonadotropin-dependent bovine follicles and cultured for 96 h in the presence or absence of FSH (granulosa) or LH (theca). The IGBP-2 and -4 specific primers amplified cDNA products of sizes 120 and 227 bp, respectively. ATPase primers were used as internal controls. The results of a representative gel for both the IGFBP-2 and -4 mRNA analyses are shown in the insets. The amplified bands were quantified by image analysis, and mRNA expression is presented in arbitrary units (mean ± SEM of three experiments). *, P < 0.05; ns, no signal.

 
PCR analysis of RNA extracted from cultures of granulosa cells failed to detect transcripts corresponding to IGFBP-4 mRNA (results not shown). This observation confirms the lack of thecal contamination of the granulosa cell cultures. Low, but detectable, expression of IGFBP-2 mRNA was observed in RNA extracted from thecal cell cultures and is probably caused by a portion of these cells being isolated from atretic follicles (see Fig. 2Go).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 2. IGFBP-2 mRNA (a) and IGFBP-4 mRNA (b) expression in granulosa (G) and theca (T) tissue from small and medium-sized (a) and small, medium, and large (b) bovine follicles, measured by in situ hybridization. N, A, and GA refer to normal, atretic, and grossly atretic follicles, respectively. The signal (% of pixels occupied by silver grains) was quantified by image analysis and presented as mean ± SEM. Bars with different subscripts indicate significant differences (P < 0.05), between stages of atresia, within cell types.

 
IGFBP-2 and -4 mRNA expression in intact follicles
In all, 65 follicles from 6 ovaries were analyzed by in situ hybridization. The follicle numbers were made up of 33 small (1–4 mm) follicles (18 healthy, 10 atretic, and 5 grossly atretic), 34 medium (4–8 mm) follicles (8 healthy, 16 atretic, and 10 grossly atretic), and 8 large (>8 mm) follicles (5 healthy, 2 atretic, and 1 grossly atretic).

IGFBP-2 mRNA was located in granulosa cells from small and medium-sized healthy antral follicles (1–8 mm in diameter) (Fig. 3Go, a and b). The granulosa cells closest to the basement membrane showed the greatest mRNA expression. In contrast, both the cumulus and the outermost layer of the mural granulosa cells did not contain IGFBP-2 mRNA. The proportion of large healthy (>8 mm) follicles expressing IGFBP-2 mRNA in granulosa tissue was significantly less ({chi}2 = 17.5; P < 0.001), compared with small (1–4 mm) and medium-sized (4–8 mm) follicles (Table 2Go). In contrast to healthy follicles, IGFBP-2 mRNA expression was detected in theca cells from atretic follicles (Fig. 2Go).



View larger version (148K):
[in this window]
[in a new window]
 
Figure 3. Dark field illuminations of serial sections (14 µm) from small, 1-mm diameter (a, b, and c) and medium, 5-mm diameter (d, e, and f) healthy bovine follicles probed with 35S-labeled antisense IGFBP-2 RNA (a and d) and IGFBP-4 RNA (b and e). Control sections (c and f) were probed with 35S-labeled sense IGFBP-2 and -4 RNA, respectively. G and T represent granulosa and theca tissue, respectively. The bar represents 100 µm.

 

View this table:
[in this window]
[in a new window]
 
Table 2. The percentage of non atretic, large (>8 mm), medium (4–8 mm) and small (1–4 mm) follicles expressing IGFBP-2 and -4 mRNA in granulosa and theca tissue respectively

 
IGFBP-4 mRNA expression was restricted to thecal tissue of healthy antral follicles (Fig. 3Go, d and e). In this case, there was no difference in expression between small, medium, and large follicles (P > 0.05). In atretic follicles of all sizes, low (but detectable) amounts of IGFBP-4 mRNA were detected in granulosa cells. Grossly atretic follicles did not express significant levels of mRNA encoding IGFBP-2 or -4 (Fig. 2Go).

Immunohistochemical localization of IGFBP-2 and -4
The spatial distribution IGFBP-2 and -4 immunoactivity was examined in six ovaries, three of which contained a healthy follicle greater than 8 mm in diameter. A representative sample of the spatial distributions observed within healthy follicles is shown in Fig. 4Go. IGFBP-2 immunoactivity was detected in granulosa tissue and the basement membrane of healthy antral follicles ranging in size from 1–8 mm in diameter (Fig. 4Go, a and c). It was not detected in large (>8 mm), healthy follicles (Fig. 4cGo).



View larger version (101K):
[in this window]
[in a new window]
 
Figure 4. Immunohistochemistry of bovine follicles probed with IGFBP-2 (a and c) and IGFBP-4 (b) antibodies. Control section (d) was incubated with normal rabbit serum. Healthy 5-mm diameter follicles (a and b); large, 14-mm diameter, healthy follicle (*); and small, 2-mm diameter, healthy follicle (c) are shown. G and T represent granulosa and theca tissue, respectively. The bar represents 50 µm.

 
In contrast to IGFBP-2, IGFBP-4 immunoactivity was detected in thecal tissue, as well as granulosa tissue and the basement membrane from healthy antral follicles of all sizes (Fig. 4bGo). Because of the cross-reactivity of the IGFBP-4 antisera with IGFBP-2, a proportion of the signal observed in granulosa tissue using this antiserum would be expected to be caused by the presence of IGFBP-2. Nevertheless, the presence of IGFBP-4 immunoreactivity in granulosa tissue of all follicles examined, including large (>8 mm in diameter), healthy follicles, which did not cross-react with IGFBP-2 antiserum, provides evidence supporting the presence of IGFBP-4 immunoreactivity in granulosa tissue.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The overall aim of this work was to understand how intrafollicular growth factors interact with systemic hormones to control follicular development. In particular, we were interested in how components of the ovarian IGF-system act to regulate follicular development in the cow. In this study, we have measured the expression of mRNA coding for IGFBP-2 and -4 in small (1–4 mm) gonadotropin-sensitive follicles and medium (4–8 mm) and large (>8 mm) gonadotropin-dependent follicles (32) by in situ hybridization, and we examined factors regulating the expression of these binding proteins in cell cultures. We have shown that IGFBP-2 and -4 mRNA expression in healthy nonatretic bovine follicles is confined to granulosa and theca tissue, respectively, and that during the development of follicular atresia, there are distinct changes in the temporal and spatial expression of these genes in vivo. IGFBP-2 immunoactivity was detected in granulosa tissue and the basement membrane of healthy antral follicles, whereas IGFBP-4 immunoactivity was detected in both theca and granulosa tissue. Of particular interest was the absence of IGFBP-2 mRNA expression in 60% of the large (>8 mm) healthy follicles examined, an observation that was confirmed by the lack of immunoreactive IGFBP-2 in healthy follicles of the same size.

By combining the results of our in vivo and in vitro studies, we are now able to shed light on three basic questions concerning the role of IGFBP-2 and -4 in regulating follicle development in the cow: 1) how the patterns of IGFBP mRNA expression in granulosa and theca tissue relate to the changes in the concentration of IGFBPs in bovine follicular fluid during folliculogenesis; 2) what mechanisms are involved in the regulation of the expression of IGFBP-2 and -4 in granulosa and theca tissue; and 3) what the roles of IGFBP-2 and -4 are in the regulation of follicle growth and the development of dominance.

The changes in IGFBP concentration in bovine follicular fluid during follicle growth and the development of dominance have been well documented (33, 34, 35) and are similar to those occurring in sheep (14, 17) and pigs (36, 37). Dominance was associated with a decrease in the concentrations of IGFBP-2 and -4 in follicular fluid. The changes in the IGFBP content of follicular fluid could arise through the regulation of IGFBP production, by changes in the activity of specific IGFBP proteases, or by changes in the selective uptake of IGFBPs from the circulation during follicle growth. In the case of IGFBP-2 mRNA expression in bovine follicles, there was no difference in expression between small (1–4 mm) and medium-sized (4–8 mm) healthy follicles. However, 60% of the large (>8 mm) healthy follicles examined did not express IGFBP-2 mRNA, and the remaining 40% expressed low levels of IGFBP-2 mRNA. This observation was supported by the absence of IGFBP-2 immunoactivity in the large (>8 mm) healthy follicles examined in this study. We conclude that the reduction in IGFBP-2 concentration in follicular fluid during the final stages of follicular growth is caused by a decrease in IGFBP-2 mRNA expression. In contrast to IGFBP-2, IGFBP-4 mRNA expression did not change during follicle growth, and the decrease in IGFBP-4 concentration in follicular fluid, in this case, is most likely to be caused by the action of specific proteases, as suggested previously by Besnard et al. (38). This group described an IGFBP-4 protease in follicular fluid of the ewe, the levels and/or activity of which increase during follicle growth.

The spatial distribution of IGFBP-2 and -4 mRNA expression between granulosa and theca tissue, described here, was similar to that described in the ewe (13, 14), but differed from that in pigs (39), rodents (40), and humans (7). Our results also highlight the variation between different subtypes of granulosa cells in relation to IGFBP-2 mRNA expression. The inner layers of the mural granulosa cells contained significantly higher amounts of IGFBP-2 mRNA, relative to the outer layer of the mural and cumulus cells. The significance of this observation, however, remains obscure.

The regulation of IGFBP-2 and -4 mRNA expression in granulosa and theca cells, respectively, was analyzed using a serum-free cell culture system. Steroid production by the primary cultures of granulosa cells was similar to that described recently (24) and indicated that the follicular phenotype was maintained for up to 4 days without significant luteinization. FSH (1 ng/ml) stimulated granulosa cell differentiation, as judged by the increase in estradiol production. However, when the cells were exposed to high (50 ng/ml) doses of FSH, estradiol production was inhibited, whereas progesterone production increased, suggesting that under those conditions, the cells were luteinized. The absence of an effect of LH on steroid production by granulosa cells isolated from medium-sized follicles suggested that these cells had yet to develop a functional LH receptor. Using this cell culture system, FSH concentrations of 50 ng/ml were shown to switch off the expression of mRNA encoding IGFBP-2 in granulosa cells. This result supports previous observations, using ovine granulosa cells, that showed decreased IGFBP-2 production in the presence of FSH (14).

The steroid profiles of thecal cell cultures used in this study indicate that the follicular phenotype of these cells can be maintained also under the culture conditions described here. Doses of LH that luteinize the cells stimulated the expression of mRNA encoding IGFBP-4. Similarly, using ovine theca cells, we have shown that LH stimulates the production of IGFBP-4 in cell-conditioned medium (14).

IGFBPs control IGF bioactivity by regulating its availability to IGF receptors (41). Immunohistochemical localization of IGFs has shown that they codistribute with the IGFBPs (42), which are often found in association with the extracellular matrix (ECM), providing an extracellular store of IGFs that can be accessed by the action of IGFBP proteases (43). Our immunohistochemical observations demonstrated the presence of both IGFBP-2 and -4 in granulosa tissue (Fig. 4Go). Immunocytochemistry revealed the presence of both these binding proteins on the plasma membranes of granulosa cells and within the ECM surrounding these cells (44). The presence of IGFBP-2 and -4 in the ECM surrounding granulosa tissue provides evidence for the existence of biologically-distinct pools of IGF, which can be differentially regulated by the action of specific proteases. In this respect, IGFBP-2 and -4 proteases with molecular weights of 36,000 and 48,000, respectively, have been shown to be produced by porcine aortic smooth-muscle cells in culture (45). Specific IGBP-2 and -4 proteases also have been demonstrated in ovine follicular fluid (38). Thus, changes in the expression of mRNA for IGFBP-2 and -4 during folliculogenesis, coupled with changes in the activity of IGFBP-specific proteases, provide a mechanism to regulate the bioavailability of IGF during follicle growth.

A major mechanistic problem in the development of dominance is how the selected follicle increases its capacity to produce estrogen during a period when circulating FSH concentrations decrease. Granulosa aromatase activity is regulated by the synergistic actions of IGF-I and FSH (1, 3, 4, 46), and hence, regulation of the intrafollicular bioactivity of IGFs may be a key mechanism in the development of dominance. Although IGFBPs inhibit IGF action on granulosa cells in vitro, our results suggest the existence of different roles for IGFBP-2 and -4 in the developing follicle in vivo. We hypothesize that IGFBP-4, produced by thecal cells, under the control of LH, is transported in association with IGFs to the ECM surrounding granulosa cells, where it acts as an extracellular storage site for IGF. Supporting this hypothesis was the observation that although mRNA encoding IGFBP-4 was confined to theca, immunoreactive protein was detected in both theca and granulosa tissue. We suggest that the IGFs associated with IGFBP-4 can then be accessed by granulosa cells through the activation/production of specific IGFBP-4 proteases (38). In contrast to IGFBP-4, IGFBP-2 produced by granulosa tissue may play an inhibitory role. After binding IGF, the affinity of IGFBP-2 for heparin-like molecules in the ECM surrounding granulosa cells increases (47). Hence, IGFBP-2 could sequester free IGF from the immediate vicinity of granulosa cells. Granulosa IGFBP-2 mRNA expression is inhibited by FSH (Fig. 2aGo), resulting in the absence of IGFBP-2 mRNA and immunoreactive IGFBP-2 in dominant follicles (Figs. 3Go and 4Go, respectively). This, combined with a corresponding increase in IGFBP-4 protease activity in large follicles (36), may increase the biological activity of intrafollicular IGFs and, in turn, increase the sensitivity of the granulosa cells to FSH, allowing the follicle to maintain responsiveness to FSH during the period when systemic FSH concentrations decrease (establishing this follicle as the dominant follicle).

The present study has described temporal and spatial changes in IGFBP-2 and -4 mRNA expression during follicular growth. The effects of LH on thecal IGFBP-4 production, and FSH on granulosa IGFBP-2 production, are described; and the importance of decreased IGFBP-2 mRNA expression in large healthy follicles, as a mechanism for the maintenance of follicle growth, is highlighted. These results will contribute to the development of hypotheses relating to the specific roles of IGFBPs in the bovine ovarian follicle.


    Footnotes
 
1 This work received support from a BBSRC core strategic grant and the Ministry of Agriculture Fisheries and Food (Grant DS-0206); from the Royal Society, UK (to A.L.G.); and from the British Council and CONACYT, Mexico (to C.G.G.). Back

2 Present address: Institute of Pediatrics, East Siberian Branch of the Russian Academy of Medical Science, Timirjazeva 16, 664003, Irkutsk, Russia. Back

Received September 3, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Adashi EY, Roban RM 1992 Intraovarian regulation. Peptidergic signalling systems. Trends Endocrinol Metab 3:243–248
  2. Armstrong DG, Webb R 1997 Ovarian follicular dominance: novel mechanisms and protein factors. Rev Reprod 2:139–146[Abstract]
  3. Giudice LC 1992 Insulin-like growth factors and ovarian development. Endocr Rev 13:641–669[CrossRef][Medline]
  4. Adashi EY, Resnick CE, Hurwitz A, Zicciarelli E, Hernandez ER, Roberts CT, LeRoith D, Rosenfeld R 1992 The intraovarian IGF system. Growth Regul 2:10–15[Medline]
  5. Oliver JE, Aitman JR, Powell JF, Wilson CA, Clayton RN 1989 IGF-I gene expression in the rat ovary is confined to granulosa cells of developing follicles. Endocrinology 124:2671–2679[Abstract]
  6. Zhou J, Adesanya OO, Vatzias G, Hammond JM, Bondy CA 1996 Selective expression of insulin-like growth factor system components during porcine ovary follicular selection. Endocrinology 137:4893–4901[Abstract]
  7. Zhou J, Bondy CA 1993 Anatomy of the human ovarian IGF system. Biol Reprod 48:467–482[Abstract]
  8. Perks CM, Dennining-Kendall PA, Gilmour RS, Wathes DC 1995 Localization of messenger ribonucleic acids for insulin-like growth factor I (IGF-I), IGF-II and the type 1 IGF receptor in the ovine ovary throughout the estrous cycle. Endocrinology 136:5266–5273[Abstract]
  9. Leeuwenberg BR, Hurst PR, McNatty KP 1995 Expression of IGF-I mRNA in the ovine ovary. J Mol Endocrinol 15:251–258[Abstract]
  10. Gutierrez CG, Campbell BK, Armstrong DG, Webb R 1997 Insulin-like growth factor-I (IGF-I) production by bovine granulosa cells in vitro and peripheral IGF-I measurement in cattle serum an evaluation of IGFBP extraction protocols. J Endocrinol 153:231–240[Abstract]
  11. Clemmons DR 1993 IGF binding proteins and their functions. Mol Reprod Dev 5:368–375
  12. Rechler MM 1993 Insulin-like growth factor binding proteins. Vitam Horm 47:1–114[Medline]
  13. Besnard N, Pisselet C, Monniaux D, Locatelli A, Benne F, Gasser F, Hatey F, Monget P 1996 Expression of messenger ribonucleic acids of insulin-like growth factor binding proteins-2, -4 and -5 in the ovine ovary localization and changes during growth and atresia of antral follicles. Biol Reprod 55:1356–1367[Abstract]
  14. Armstrong DG, Hogg CO, Campbell BK, Webb R 1996 Insulin-like growth factor (IGF) binding protein production by primary cultures of ovine granulosa and theca cells. The effect of IGF-I, gonadotropin and follicle size. Biol Reprod 55:1163–1171[Abstract]
  15. Grimes RW, Barber JA, Shimasaki S, Ling N, Hammond JM 1994 Porcine ovarian granulosa cells secrete insulin-like growth factor-binding proteins-4 and -5 and express their messenger ribonucleic acids: regulation by follicle-stimulating hormone and insulin-like growth factor-I. Biol Reprod 50:695–701[Abstract]
  16. El-Roeiy A, Chen X, Roberts VJ, Shimasaki S, Ling N, LeRoith D, Roberts Jr CT, Yen SSC 1994 Expression of the genes encoding the insulin-like growth factors (IGF-I and -II) the IGF and insulin receptors and IGF-binding proteins 1–6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab 78:1488–1496[Abstract]
  17. Monget P, Monniaux D, Pisselet C, Durand P 1993 Changes in insulin-like growth -I (IGF-I), IGF-II and their binding proteins during growth and atresia of ovine ovarian follicles. Endocrinology 132:1438–1446[Abstract]
  18. Spicer LJ, Stewart RC, Avarey P, Francisco CC, Keefer BE 1997 Insulin-like growth factor-binding protein-2 and -3:their biological effects in bovine thecal cells. Biol Reprod 56:1458–1465[Abstract]
  19. Mason HD, Willis D, Holly JMP, Cwyfan-Hughes SC, Seppala M, Franks S 1992 Inhibitory effects of insulin-like growth factor-binding proteins on steroidogenesis by human granulosa cells in culture. Mol Cell Endocrinol 89:R1–R4
  20. Webb R, Gong JG, Law AS, Rusbridge SM 1992 Control of ovarian function in cattle. J Reprod Fertil [Suppl]45:141–156
  21. Gong JG, Webb R 1996 Control of ovarian follicle development in domestic ruminants: its manipulation to increase ovulation rate and improve reproductive performance. Anim Breeding Abstracts 64:195–204
  22. Ginther OJ, Wiltbank MC, Fricke PM, Gibbons JR, Kot K 1996 Selection of the dominant follicle in cattle. Biol Reprod 55:1187–1194[CrossRef][Medline]
  23. Campbell BK, Scaramuzzi RJ, Webb R 1996 Induction and maintenance of oestradiol and immunoreactive inhibin production with FSH by ovine granulosa cells cultured in serum free media. J Reprod Fertil 106:7–16[Abstract]
  24. Gutierrez CG, Campbell BK, Webb R 1997 Development of a long-term bovine granulosa cell culture system: induction and maintenance of oestradiol production, response to follicle stimulating hormone and morphological characteristics. Biol Reprod 56:608–616[Abstract]
  25. Xu ZZ, Garverick HA, Smith GW, Smith, MF, Hamilton SA, Younquist RS 1995 Expression of follicle-stimulating hormone and luteinizing hormone receptor messenger ribonucleic acids in bovine follicles during the first follicular wave. Biol Reprod 53:951–957[Abstract]
  26. Campbell BK, Baird DT, Webb R J Reprod Fertil, in press
  27. Armstrong DG, Hogg CO 1992 The expression of a putative growth factor-1 receptor gene in the liver of the developing chick. J Mol Endocrinol 8:193–201[Abstract]
  28. Bourner MJ, Busby WH, Siegel NR, Krivi GG, McCusker RH, Clemmons DR 1992 Cloning and sequence determination of bovine insulin-like growth factor-binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1. J Cell Biochem 48:215–226[CrossRef][Medline]
  29. Xu ZZ, Garverick HA, Smith GW, Smith MF, Hamilton SA, Younquist RS 1995 Expression of messenger ribonucleic acid encoding cytochrome P450 side-chain cleavage, cytochrome P450 17{alpha}-hydroxylase, and cytochrome P450 aromatase in bovine follicles during the first follicular wave. Endocrinology 136:981–989[Abstract]
  30. Corrie JET, Hunter WM, MacPherson JS 1981 A strategy for radioimmunoassay of plasma progesterone with the use of a homologous site 125I-labelled radioligand. Clin Chem 27:594–599[Abstract/Free Full Text]
  31. Webb R, Baxter G, McBride D, Nordblom GD, Shaw MPK 1985 The measurement of testosterone and estradiol-17b using iodinated tracers and incorporating an affinity chromatography extraction procedure. J Steroid Biochem Mol Biol 23:1043–1051
  32. Gong JG, Campbell BK, Bramley TA, Gutierrez CG, Peters AR, Webb R 1996 Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicular development in heifers continuously infused with gonadotropin-releasing hormone agonist. Biol Reprod 55:68–74[Abstract]
  33. Echternkamp SE, Howard HJ, Roberts AJ, Grizzle J, Wise T 1994 Relationships among concentrations of steroids, insulin-like growth factor-I, and insulin-like growth factor binding proteins in ovarian follicular fluid of beef cattle. Biol Reprod 51:971–981[Abstract]
  34. de la Sota RL, Simmen FA, Diaz T, Thatcher WW 1996 Insulin-like growth factor system in first-wave dominant and subordinate follicles. Biol Reprod 55:803–812[Abstract]
  35. Funston RN, Seidel Jr GE, Klindt J, Roberts AJ 1996 Insulin-like growth factor 1 and insulin-like growth factor binding proteins in bovine serum and follicular fluid before and after the preovulatory surge of luteinizing hormone. Biol Reprod 55:1390–1396[Abstract]
  36. Mondschein JS, Etherton TD, Hammond JM 1991 Characterization of insulin-like binding proteins of porcine ovarian follicular fluid. Biol Reprod 44:315–320[Abstract]
  37. Guthrie HD, Grimes RW, Hammond JM 1995 Changes in insulin-like growth factor binding protein-2 and -3 in follicular fluid during atresia of follicles grown after ovulation in pigs. J Reprod Fertil 104:225–230[Abstract]
  38. Besnard N, Pisselet C, Zapf J, Hornebeck W, Monniaux D, Monget P 1996 Proteolytic activity is involved in changes in intrafollicular insulin-like growth factor binding protein levels during growth and atresia of ovine follicles. Endocrinology 137:1599–1607[Abstract]
  39. Yuan W, Lucy M, Smith MF 1996 Messenger ribonucleic acid for insulin-like growth factors-I and -II, insulin-like growth factor binding protein-2, gonadotropin receptors, and steroidogenic enzymes in porcine follicles. Biol Reprod 55:1045–1054[Abstract]
  40. Ling NC, Liu XJ, Malkowski LM, Gua YL, Erickson GF, Shimasaki S 1993 Structural and functional studies of the insulin-like growth factor binding proteins in the ovary. Growth Regul 3:70–74[Medline]
  41. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34[CrossRef][Medline]
  42. Hill DJ, Clemmons DR, Wilson S, Han VKM, Strain AJ, Milner RDG 1989 Immunological distribution of one form of insulin-like growth factor (IGF)-binding protein and IGF peptides in fetal tissue. J Mol Endocrinol 2:31–38[Abstract]
  43. Logan AL, Hill DJ 1992 Bioavailability. Is this a key event in regulating the actions of peptide growth factors? J Endocrinol 134:157–161[Medline]
  44. Glazyrin AL, Armstrong DG, Gutierrez CG, Bramely TA, Webb R 1996 Expression of IGF-binding protein -4 messenger ribonucleic acid and ultrastructural localization of the gene product in the bovine ovary. J Reprod Fertil Abstr Ser 17:Abstract 31
  45. Parker A, Gockerman A, Busby WH, Clemmons DR 1995 Properties of an insulin-like growth factor binding protein -4 protease that is secreted by smooth muscle cells. Endocrinology 136:2470–2476[Abstract]
  46. Campbell BK, Scaramuzzi RJ, Webb R 1995 Control of antral follicle development and selection in sheep and cattle. J Reprod Fertil [Suppl] 49:335–350[Medline]
  47. Arai T, Busby Jr W, Clemmons DR 1966 Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Endocrinology 137:4571–4575[Abstract]
  48. Moser DR, Lowe Jr WL, Dake BL, Booth BA, Boes M, Clemmons DR, Bar RS 1992 Endothelial cells express insulin-like growth factor-binding proteins 2 to 6. Mol Endocrinol 6:1805–1814[Abstract]



This article has been cited by other articles:


Home page
ReproductionHome page
F. H Thomas, B. K Campbell, D. G Armstrong, and E. E Telfer
Effects of IGF-I bioavailability on bovine preantral follicular development in vitro
Reproduction, June 1, 2007; 133(6): 1121 - 1128.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S Llewellyn, R Fitzpatrick, D A Kenny, J J Murphy, R J Scaramuzzi, and D C Wathes
Effect of negative energy balance on the insulin-like growth factor system in pre-recruitment ovarian follicles of post partum dairy cows
Reproduction, March 1, 2007; 133(3): 627 - 639.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
K. A Walters, J. P Binnie, B. K Campbell, D. G Armstrong, and E. E Telfer
The effects of IGF-I on bovine follicle development and IGFBP-2 expression are dose and stage dependent.
Reproduction, March 1, 2006; 131(3): 515 - 523.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
B. Nicholas, R. Alberio, A.A. Fouladi-Nashta, and R. Webb
Relationship Between Low-Molecular-Weight Insulin-Like Growth Factor-Binding Proteins, Caspase-3 Activity, and Oocyte Quality
Biol Reprod, April 1, 2005; 72(4): 796 - 804.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
E D Watson, S-E Bae, R Thomassen, S R M Thomson, K Woad, and D G Armstrong
Insulin-like growth factors-I and -II and insulin-like growth factor-binding protein-2 in dominant equine follicles during spring transition and the ovulatory season
Reproduction, September 1, 2004; 128(3): 321 - 329.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. J. Spicer
Proteolytic Degradation of Insulin-Like Growth Factor Binding Proteins by Ovarian Follicles: A Control Mechanism for Selection of Dominant Follicles
Biol Reprod, May 1, 2004; 70(5): 1223 - 1230.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
S. M. Quirk, R. G. Cowan, R. M. Harman, C.-L. Hu, and D. A. Porter
Ovarian follicular growth and atresia: The relationship between cell proliferation and survival
J Anim Sci, January 1, 2004; 82(13_suppl): E40 - 52.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
R. Webb, P. C. Garnsworthy, J.-G. Gong, and D. G. Armstrong
Control of follicular growth: Local interactions and nutritional influences
J Anim Sci, January 1, 2004; 82(13_suppl): E63 - 74.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
A. J. Roberts and S. E. Echternkamp
Insulin-like growth factor binding proteins in granulosa and thecal cells from bovine ovarian follicles at different stages of development
J Anim Sci, November 1, 2003; 81(11): 2826 - 2839.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. M. Rivera and J. E. Fortune
Proteolysis of Insulin-Like Growth Factor Binding Proteins -4 and -5 in Bovine Follicular Fluid: Implications for Ovarian Follicular Selection and Dominance
Endocrinology, July 1, 2003; 144(7): 2977 - 2987.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. Zhou, J. Wang, D. Penny, P. Monget, J. A. Arraztoa, L. J. Fogelson, and C. A. Bondy
Insulin-Like Growth Factor Binding Protein 4 Expression Parallels Luteinizing Hormone Receptor Expression and Follicular Luteinization in the Primate Ovary
Biol Reprod, July 1, 2003; 69(1): 22 - 29.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P. Monget, S. Mazerbourg, T. Delpuech, M.-C. Maurel, S. Maniere, J. Zapf, G. Lalmanach, C. Oxvig, and M. T. Overgaard
Pregnancy-Associated Plasma Protein-A Is Involved in Insulin-Like Growth Factor Binding Protein-2 (IGFBP-2) Proteolytic Degradation in Bovine and Porcine Preovulatory Follicles: Identification of Cleavage Site and Characterization of IGFBP-2 Degradation
Biol Reprod, January 1, 2003; 68(1): 77 - 86.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. A. Arraztoa, P. Monget, C. Bondy, and J. Zhou
Expression Patterns of Insulin-Like Growth Factor-Binding Proteins 1, 2, 3, 5, and 6 in the Mid-Cycle Monkey Ovary
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5220 - 5228.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. R. Davidson, C. S. Chamberlain, T. S. Bridges, and L. J. Spicer
Effect of Follicle Size on In Vitro Production of Steroids and Insulin-Like Growth Factor (IGF)-I, IGF-II, and the IGF-Binding Proteins by Equine Ovarian Granulosa Cells
Biol Reprod, June 1, 2002; 66(6): 1640 - 1648.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M.A. Beg, D.R. Bergfelt, K. Kot, and O.J. Ginther
Follicle Selection in Cattle: Dynamics of Follicular Fluid Factors During Development of Follicle Dominance
Biol Reprod, January 1, 2002; 66(1): 120 - 126.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. Hoeflich, R. Reisinger, H. Lahm, W. Kiess, W. F. Blum, H. J. Kolb, M. M. Weber, and E. Wolf
Insulin-like Growth Factor-binding Protein 2 in Tumorigenesis: Protector or Promoter?
Cancer Res., December 1, 2001; 61(24): 8601 - 8610.
[Full Text] [PDF]


Home page
Biol. Reprod.Home page
O.J. Ginther, M.A. Beg, D.R. Bergfelt, F.X. Donadeu, and K. Kot
Follicle Selection in Monovular Species
Biol Reprod, September 1, 2001; 65(3): 638 - 647.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J.E. Fortune, G.M. Rivera, A.C.O. Evans, and A.M. Turzillo
Differentiation of Dominant Versus Subordinate Follicles in Cattle
Biol Reprod, September 1, 2001; 65(3): 648 - 654.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
G.M. Rivera, Y.A. Chandrasekher, A.C.O. Evans, L.C. Giudice, and J.E. Fortune
A Potential Role for Insulin-Like Growth Factor Binding Protein-4 Proteolysis in the Establishment of Ovarian Follicular Dominance in Cattle
Biol Reprod, July 1, 2001; 65(1): 102 - 111.